Topics: Antineoplastic Agents, chemotherapy, Antineoplastic Agents, Treatment-induced tumor, Cancer chemotherapeutic agents, cell cycle, Cell-cycle non specific agents, Cell-cycle specific agents, Hormone therapy, hormone antagonists, Endocrine therapy, Corticosteroids, Estrogens, Progestons, Goserelin Acetate, gonadotropin, GnRH analogues, gonadotropin-releasing hormone, tamoxifen, SELECTIVE ESTROGEN RECEPTOR MODULATORS, breast cancer, Tamoxifen Raloxifen Torimefene, ANTI ESTROGENS, FULVESTRANT, SELECTIVE ESTROGEN RECEPTOR DOWNREGULATOR, AROMATASE INHIBITORS, Letrozole, Anastrazole, Exemestane, LHRH AGONISTS, Leuprolide, Goserelin, PROGESTINS, Megestrol acetate, Medroxyprogesterone acetate, prostrate cancer

Topics: gastrointestinal tract, gastrointestinal tract disorder, gastrointestinal hypermotility, gastrointestinal hypomotility

Topics: Hypnotic drugs, Benzodiazepines, Nonbenzodiazepines, Antipsychotics, Antihistamines

Topics: Viral Oncogenesis, tumour immunology, carcinoma, tumor cells, NK cells, Macrophages

Topics: tumor development, tumor initiation, tumor promotion, Immune cells, macrophages, Tumor-associated macrophages, angiogenesis, metastasis, Anti-inflammatory drugs

Topics: Tuberculosis, Bacille Camette-Guerin.Hepatitis B, polio, Diphtheria, Tetanus, Pertussis, Haemophilus influenzae, pneumococcal, measles, Rubella, Human Papillomavirus, yellow fever

Topics: COMBINATION THERAPY, LACTAMS, penicillins, cephalosporins, Antimicrobial Spectrum, Semisynthetic Penicillins, LACTAM ALLERGY, SULFONAMIDES, TRIMETHOPRIM-SULFAMETHOXAZOLE, QUINOLONES, URINARY TRACT ANTISEPTICS, sulfanilamide, para-aminobenzene sulfonamide, quinolone, CIPROFLOXACIN, OFLOXACIN, SPARFLOXACIN

Topics: dapsone, leprosy

Topics: Erythromycin, Clarithromycin, Azithromycin, Ketolides, Telithromycin, LINCOSAMIDES

Topics: Peritoneovenous Shunting, Intracavitary Chemotherapy, Mechlorethiamine, cis-diammine dichloroplatinum, Cisplatin, mitomycin, Fluorouracil, Intraperitoneal triamcinolone hexacetanide, Hyperthermic Chemotherapy, Angio-inhibitory therapy, Catumaxomab, Malignant pleural effusion